| PEGCETACOPLAN | None | ||
| 1080MG/20ML |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| EMPAVELI is a complement inhibitor indicated for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH). | |||
|
Yes
| |||
| EMPAVELI | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||
| ****** ********** ******* | ********** ******* **** ******** ******** | ****** ********** ******* | ****-********, ****-******, ** ******** ********** ******* *** ******* ************ *** ******* | ****-********, ****-******, ** ******** ********** ******* *** **** ******* | ****-********, ****-******, ** ******** ********** ******* *** ******* ************ *** ******* | ****** ******** *** ******* ************ *** ******* | ****-********, ****-******, ** ******** ********** ******* *** ******* ************ *** ******* | ****-********, ****-******, ** ******** ********** ******* *** **** ******* | ****** ******** *** ******* ************ *** ******* | ****** ******** *** ******* ************ *** ******* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|